M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer
Pancreatic cancer is a malignant disease with high mortality and poor prognosis due to lack of early diagnosis and low treatment efficiency after diagnosis. Although Gemcitabine (GEM) is used as the first-line chemotherapeutic drug, chemoresistance is still the major problem that limits its therapeu...
Saved in:
Main Authors: | Yongmei Zhao (Author), Yuanlin Zheng (Author), Yan Zhu (Author), Yi Zhang (Author), Hongyan Zhu (Author), Tianqing Liu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Enhancing efficacy of gemcitabine in pancreatic patient-derived xenograft mouse models
by: Andriana Inkoom, et al.
Published: (2020) -
Berberine Overcomes Gemcitabine-Associated Chemoresistance through Regulation of Rap1/PI3K-Akt Signaling in Pancreatic Ductal Adenocarcinoma
by: Keisuke Okuno, et al.
Published: (2022) -
Exosomes secreted by chemoresistant ovarian cancer cells promote angiogenesis
by: Zhang Li, et al.
Published: (2021) -
Gemcitabine-Vitamin E Prodrug-Loaded Micelles for Pancreatic Cancer Therapy
by: Miguel Pereira-Silva, et al.
Published: (2024) -
Modified Gold Nanoparticles to Overcome the Chemoresistance to Gemcitabine in Mutant p53 Cancer Cells
by: Eduardo García-Garrido, et al.
Published: (2021)